Glioblastoma News and Research

RSS
Glioblastoma is the most aggressive and malignant form of glioma, a type of primary brain cancer. Surgery is often used to treat gliomas, along with radiation. However, since surgery and radiation fail to cure the disease, doctors may turn to additional radiation or chemotherapy. In early stages glioblastoma tumors often grow without symptoms and therefore can become quite large before symptoms arise. When the tumor becomes symptomatic, tumor growth is usually very rapid and is accompanied by altered brain function, and if left untreated the disease becomes lethal. Although primary treatment is often successful in temporarily stopping the progression of the tumor, glioblastomas almost always recur and become lethal.
Researchers identify new form of treatment for brain tumor

Researchers identify new form of treatment for brain tumor

Cocktail eradicates animals' brain tumors

Cocktail eradicates animals' brain tumors

Phase 1/2 clinical trial data for VAL-083 in glioblastoma is presented at 18th Annual SNO meeting

Phase 1/2 clinical trial data for VAL-083 in glioblastoma is presented at 18th Annual SNO meeting

Researchers create new statistical tools to find clues about cancer from raw data

Researchers create new statistical tools to find clues about cancer from raw data

Polymer for mending broken bones holds hope for delivering chemotherapy drugs to the brain

Polymer for mending broken bones holds hope for delivering chemotherapy drugs to the brain

Delmar Pharmaceuticals announces quarterly update, strengthens intellectual property portfolio

Delmar Pharmaceuticals announces quarterly update, strengthens intellectual property portfolio

GW Pharmaceuticals starts Phase 1b/2a clinical trial for Recurrent Glioblastoma Multiforme

GW Pharmaceuticals starts Phase 1b/2a clinical trial for Recurrent Glioblastoma Multiforme

TGen-led study reveals viable target to prevent spread of brain cancer

TGen-led study reveals viable target to prevent spread of brain cancer

Cytrx announces Q3 2013 financial results, provides clinical update

Cytrx announces Q3 2013 financial results, provides clinical update

FDA grants orphan drug designation to Aduro's CRS-207 for treatment of pancreatic cancer

FDA grants orphan drug designation to Aduro's CRS-207 for treatment of pancreatic cancer

Angiochem initiates ANG1005 Phase 2 study in patients with recurrent high-grade glioma

Angiochem initiates ANG1005 Phase 2 study in patients with recurrent high-grade glioma

Study opens doors to novel treatments for aggressive brain cancer

Study opens doors to novel treatments for aggressive brain cancer

New investigational drug offers potential treatment option for lung cancer

New investigational drug offers potential treatment option for lung cancer

Research delves deeply into genomics of glioblastoma multiforme cases to better target disease

Research delves deeply into genomics of glioblastoma multiforme cases to better target disease

Sahlgrenska Academy study finds no traces of viruses in breast cancer and glioblastoma

Sahlgrenska Academy study finds no traces of viruses in breast cancer and glioblastoma

Researchers discover drug that halts growth of brain tumor cells

Researchers discover drug that halts growth of brain tumor cells

Applied Integrin Sciences' drug candidate eliminates ovarian cancer tumors in pre-clinical study

Applied Integrin Sciences' drug candidate eliminates ovarian cancer tumors in pre-clinical study

Nanodiamonds deliver chemotherapy directly into brain tumors

Nanodiamonds deliver chemotherapy directly into brain tumors

Umbilical cord mesenchymal stem cells may have targeting capacity for glioma

Umbilical cord mesenchymal stem cells may have targeting capacity for glioma

New drug delivery system using NDs allows for direct application of chemotherapy to brain tumors

New drug delivery system using NDs allows for direct application of chemotherapy to brain tumors

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.